Market News

3 min read | Updated on July 10, 2026, 11:05 IST
SUMMARY
Blue Jet Healthcare approved the issue and allotment of shares to investors, raising ₹800 crore from the QIP issue. Check the details on which institutional investors received the allotment.
Stock list

Blue Jet Healthcare’s investment and finance committee approved the issue and allotment of QIP issue to investors on the evening of July 9. | Image: Shutterstock
Blue Jet Healthcare shares surged more than 8% during the trading session on Friday, July 10, after the company successfully raised ₹800 crore via a qualified institutional placement (QIP) issue, according to an exchange filing.
NSE filings showed that Blue Jet Healthcare’s investment and finance committee, after its meeting on July 9, approved the issue and allotment of equity shares to qualified institutional buyers (QIBs) at a price of ₹506 per share.
Shares of Blue Jet Healthcare surged 8.5% to an early market high of ₹623.35 on Friday’s market, compared to ₹574.50 at the previous stock market close, according to NSE data. The company announced its QIP update after the market hours on July 9.
At 10:42 am, Blue Jet Healthcare stock was trading 5.9% higher at ₹608.80 during the trading session as investors reacted to the company securing funds from the market QIB investors.
Blue Jet Healthcare’s filing data also showed that only two Qualified Institutional Buyers (QIBs) were allocated around 68% of the shares reserved for the QIP fundraise equity shares issue.
Shamyak Investment Pvt.Ltd, a systematically important non-banking financial company (NBFC), and ICICI Prudential Mutual Fund were allocated the equity shares, according to the exchange filing.
The company allocated a total of 54,34,785 equity shares to Shamyak Investment, and allocated a total of 53,35,974 equity shares to ICICI Prudential Mutual Fund dividend into seven funds.
According to the exchange filing, Blue Jet Healthcare issued 15,810,276 equity shares with a face value of ₹2 apiece at an issue price of ₹506 apiece, as the company raised a total of ₹800 crore via the QIP move.
This comes after the company, in its Q4 results, announced its plans to raise around ₹1,000 crore through QIP preferential allotments, subject to the approval of the shareholders.
NSE data showed that 79.81% of the total stake of the company is owned by the promoter and promoter group entities, while 20.19% of the stake is owned by the public shareholders, as of the quarter ended June 30, 2026.
The QIP issue opened on July 6, 2026, and closed after the trading session on July 9, 2026, as per the exchange filing.
Blue Jet Healthcare shares have lost 22% in the last one-year period, according to NSE data. However, the company’s stock has delivered 15% returns to investors on a year-to-date basis in the current calendar year.
In the last one month, the company shares have gained more than 29%, and were trading over 9% higher in the last five trading sessions on the stock exchange.
Shares of Blue Jet Healthcare hit their 52-week high of ₹1,027.80 on July 21, 2025, while the 52-week low was at ₹325 on March 30, 2026. The company’s market capitalisation (m-cap) was at ₹10, 527 crore as of the trading session on Friday, July 10, 2026.
Related News
About The Author

Next Story
How To Use Open Interest For Intraday Trading: Complete Guide
What Is Stop Loss In Trading? Meaning, Types, & How To Use It
What Is ICRA? Why Its Credit Ratings Matter To Investors
Explore Learning Centre
All topics · stocks, MFs, derivatives, IPOs